Pulmatrix, Inc.
US ˙ NasdaqCM ˙ US74584P3010

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Matthew L Sherman. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Matthew L Sherman telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
EVP & Chief Medical Officer 0
US:PIRS / Pieris Pharmaceuticals, Inc. Director 40,000
Director 13,889
US:PULM / Pulmatrix, Inc. Director 15,000
US:XLRN / Acceleron Pharma Inc EVP & Chief Medical Officer 68,767
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Matthew L Sherman. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam PULM / Pulmatrix, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di PULM / Pulmatrix, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2018-04-03 PULM Sherman Matthew L 20,000 1,333 69 120

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

PULM / Pulmatrix, Inc. Insider Trades
Penjualan Orang Dalam PULM / Pulmatrix, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di PULM / Pulmatrix, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

PULM / Pulmatrix, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Matthew L Sherman sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2024-06-11 2024-06-11 4 NA Deciphera Pharmaceuticals, Inc.
Common Stock
U - Other -72,261 0 -100.00
2024-06-11 2024-06-11 4 NA Deciphera Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -72,029 72,261 -49.92
2024-06-11 2024-06-11 4 NA Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 34,157 144,290 31.01
2024-02-20 2024-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2,615 108,739 -2.35 15.62 -40,840 1,698,253
2024-02-20 2024-02-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 17,275 111,354 18.36
2024-01-18 2024-01-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2,435 94,079 -2.52 14.47 -35,234 1,361,295
2023-12-14 2023-12-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2,792 96,514 -2.81 15.37 -42,905 1,483,140
2023-12-14 2023-12-12 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 8,244 99,306 9.05
2023-10-31 2023-10-30 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2,360 90,628 -2.54 12.02 -28,362 1,089,131
2023-10-31 2023-10-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 8,244 92,988 9.73
2023-10-04 2023-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2,942 84,744 -3.36 12.68 -37,305 1,074,554
2023-06-21 2023-06-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -1,655 87,686 -1.85 14.40 -23,835 1,262,836
2023-02-17 2023-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -971 88,145 -1.09 15.10 -14,661 1,330,901
2023-02-17 2023-02-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 16,488 89,116 22.70
2023-01-19 2023-01-17 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2,403 72,628 -3.20 21.24 -51,043 1,542,713
2022-10-05 2022-10-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2,587 74,297 -3.36 18.73 -48,455 1,391,583
2022-06-21 2022-06-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -1,768 76,884 -2.25 10.75 -19,006 826,503
2022-02-18 2022-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -984 76,790 -1.27 9.05 -8,905 694,950
2022-01-20 2022-01-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 82,000 82,000
2022-01-20 2022-01-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 20,500 77,774 35.79
2021-12-17 2021-12-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 82,265 82,265
2021-12-17 2021-12-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 11,100 57,274 24.04
2021-10-06 2021-10-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2,659 46,029 -5.46 33.17 -88,199 1,526,782
2021-06-29 2021-06-25 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 40,000 40,000
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 49,900 49,900
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 11,100 48,386 29.77
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -132 37,286 -0.35 48.87 -6,451 1,822,167
2020-12-11 2020-12-09 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to buy)
M - Exercise -207 147,096 -0.14
2020-12-11 2020-12-09 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 207 37,418 0.56 34.43 7,127 1,288,302
2020-11-18 2020-11-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to buy)
M - Exercise -2,697 147,303 -1.80
2020-11-18 2020-11-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 2,697 37,211 7.81 34.43 92,858 1,281,175
2020-10-06 2020-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
F - Taxes -2,632 34,128 -7.16 51.15 -134,618 1,745,535
2020-06-25 2020-06-23 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 40,000 40,000
2020-02-20 2020-02-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award -10,520 10,520 -50.00
2020-02-20 2020-02-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 1,760 36,760 5.03
2020-01-28 2020-01-25 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20,000 20,000
2019-10-17 2019-10-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 150,000 150,000
2019-10-17 2019-10-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 35,000 35,000
2019-08-02 2019-07-31 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 13,889 13,889
2019-08-02 2019-07-31 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
D - Sale to Issuer -27,777 0 -100.00
2019-08-02 2019-07-31 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 18,506 18,506
2019-08-02 2019-07-31 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 13,218 13,218
2019-08-02 2019-07-31 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
D - Sale to Issuer -63,447 0 -100.00
2019-05-20 2019-05-16 4 PULM Pulmatrix, Inc.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2019-05-14 2019-05-10 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 25,000 25,000
2019-01-29 2019-01-25 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20,000 20,000
2018-10-25 2018-10-24 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 30,000 30,000
2018-06-06 2018-06-05 4 PULM Pulmatrix, Inc.
Stock Option (Right to Buy)
A - Award 124,000 124,000
2018-05-25 2018-05-23 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 27,777 27,777
2018-04-05 2018-04-03 4 PULM Pulmatrix, Inc.
Series A Warrant (right to buy)
P - Purchase 20,000 20,000
2018-04-05 2018-04-03 4 PULM Pulmatrix, Inc.
Series B Warrant (right to buy)
P - Purchase 20,000 20,000
2018-04-05 2018-04-03 4 PULM Pulmatrix, Inc.
Common Stock
P - Purchase 20,000 20,000
2018-04-04 2018-04-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -900 68,767 -1.29 39.04 -35,136 2,684,664
2018-04-04 2018-04-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -3,700 69,667 -5.04 38.28 -141,636 2,666,853
2018-01-04 2018-01-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,033 73,367 -2.70 43.33 -88,090 3,178,992
2018-01-04 2018-01-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,300 75,400 -2.96 42.40 -97,520 3,196,960
2018-01-04 2018-01-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -300 77,700 -0.38 40.86 -12,258 3,174,822
2017-09-14 2017-09-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -150 78,000 -0.19 39.91 -5,986 3,112,980
2017-09-14 2017-09-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,600 78,150 -2.01 39.24 -62,784 3,066,606
2017-09-14 2017-09-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -16,650 79,750 -17.27 38.32 -638,028 3,056,020
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -8,000 0 -100.00
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -16,000 96,400 -14.23 32.00 -512,000 3,084,800
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 8,000 112,400 7.66 7.12 56,960 800,288
2017-03-22 2017-03-20 4 PULM Pulmatrix, Inc.
Stock Option (Right to Buy)
A - Award 4,400 4,400
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 47,300 47,300
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 7,900 104,400 8.19
2017-01-06 2017-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,600 96,500 -1.63 27.62 -44,192 2,665,330
2017-01-06 2017-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -400 98,100 -0.41 26.81 -10,724 2,630,061
2016-10-03 2016-09-29 4 PULM Pulmatrix, Inc.
Stock Option (Right to Buy)
A - Award 8,800 8,800
2016-08-11 2016-08-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise -17,000 8,000 -68.00
2016-08-11 2016-08-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise -1,896 0 -100.00
2016-08-11 2016-08-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 17,000 98,500 20.86 7.12 121,040 701,320
2016-08-11 2016-08-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 1,896 81,500 2.38 5.28 10,011 430,320
2016-07-07 2016-07-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise -6,000 1,896 -75.99
2016-07-07 2016-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 6,000 79,604 8.15 5.28 31,680 420,309
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,604 7,896 -36.83
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -3,500 0 -100.00
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -5,896 0 -100.00
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -20,207 73,604 -21.54 34.89 -705,022 2,568,044
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -5,793 93,811 -5.82 34.20 -198,121 3,208,336
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,604 99,604 4.85 5.28 24,309 525,909
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 3,500 95,000 3.83 3.88 13,580 368,600
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5,896 91,500 6.89 5.08 29,952 464,820
2016-04-08 2016-04-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -14,000 5,896 -70.37
2016-04-08 2016-04-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -23,920 85,604 -21.84 32.00 -765,440 2,739,328
2016-04-08 2016-04-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 14,000 109,524 14.66 5.08 71,120 556,382
2016-04-08 2016-04-06 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,080 95,524 -2.13 32.00 -66,560 3,056,768
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 36,000 36,000
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 6,000 97,604 6.55
2015-10-16 2015-10-15 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -500 8,500 -5.56 23.94 -11,970 203,490
2015-10-16 2015-10-15 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -700 9,000 -7.22 22.69 -15,883 204,210
2015-10-16 2015-10-15 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,400 91,604 -2.55 23.93 -57,432 2,192,084
2015-10-16 2015-10-15 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,400 94,004 -2.49 22.66 -54,384 2,130,131
2015-09-18 2015-09-16 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -400 9,700 -3.96 34.96 -13,984 339,112
2015-09-18 2015-09-16 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -200 96,404 -0.21 34.93 -6,986 3,367,392
2015-09-18 2015-09-16 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -300 96,604 -0.31 33.55 -10,065 3,241,064
2015-09-18 2015-09-16 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,100 96,904 -1.12 32.22 -35,442 3,122,247
2015-09-11 2015-09-09 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 46,000 98,004 88.45
2015-08-25 2015-08-24 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise -20,000 3,500 -85.11
2015-08-25 2015-08-24 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 20,000 52,004 62.49 3.88 77,600 201,776
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -1,600 19,896 -7.44
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 0 -100.00
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -200 10,100 -1.94 31.69 -6,338 320,069
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -200 10,100 -1.94 31.69 -6,338 320,069
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -800 10,300 -7.21 30.99 -24,792 319,197
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -400 11,100 -3.48 31.95 -12,780 354,645
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,400 32,204 -4.17 31.00 -43,400 998,324
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1,600 33,604 5.00 5.08 8,128 170,708
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,210 32,004 -3.64 31.60 -38,236 1,011,326
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,790 33,214 -7.75 30.83 -86,016 1,023,988
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 36,004 12.50 0.48 1,920 17,282
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -800 21,496 -3.59
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 4,000 -50.00
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -200 11,500 -1.71 33.22 -6,644 382,030
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,000 11,700 -7.87 32.31 -32,310 378,027
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -800 32,004 -2.44 33.22 -26,576 1,063,173
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 800 32,804 2.50 5.08 4,064 166,644
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -100 32,004 -0.31 32.74 -3,274 1,047,811
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -3,900 32,104 -10.83 32.29 -125,931 1,036,638
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 36,004 12.50 0.48 1,920 17,282
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -1,600 22,296 -6.70
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 8,000 -33.33
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -400 12,700 -3.05 31.07 -12,428 394,589
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,000 13,100 -7.09 31.57 -31,570 413,567
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -5,600 32,004 -14.89 31.57 -176,792 1,010,366
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1,600 37,604 4.44 5.08 8,128 191,028
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 36,004 12.50 0.48 1,920 17,282
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -1,600 23,896 -6.28
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 12,000 -25.00
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,400 14,100 -9.03 32.20 -45,080 454,020
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -5,600 32,004 -14.89 32.41 -181,496 1,037,250
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1,600 37,604 4.44 5.08 8,128 191,028
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 36,004 12.50 0.48 1,920 17,282
2015-04-21 2015-04-20 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 16,000 -20.00
2015-04-21 2015-04-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,000 15,500 -6.06 33.50 -33,500 519,250
2015-04-21 2015-04-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -4,000 32,004 -11.11 33.53 -134,120 1,073,094
2015-04-21 2015-04-20 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 36,004 12.50 0.48 1,920 17,282
2015-04-17 2015-04-16 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise -12,000 23,500 -33.80
2015-04-17 2015-04-16 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 12,000 32,004 59.99 3.88 46,560 124,176
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -800 25,496 -3.04
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 20,000 -16.67
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -200 16,500 -1.20 41.21 -8,242 679,965
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -100 16,700 -0.60 41.60 -4,160 694,720
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -900 16,800 -5.08 41.13 -37,017 690,984
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -800 20,004 -3.85 41.21 -32,968 824,365
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 800 20,804 4.00 5.08 4,064 105,684
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -721 20,004 -3.48 41.63 -30,015 832,767
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -3,279 20,725 -13.66 41.07 -134,669 851,176
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 24,004 20.00 0.48 1,920 11,522
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 15,000 15,000
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -1,600 26,296 -5.74
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 24,000 -14.29
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -300 17,700 -1.67 41.38 -12,414 732,426
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -700 18,000 -3.74 40.63 -28,441 731,340
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -400 18,700 -2.09 40.92 -16,368 765,204
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,600 20,004 -7.41 40.21 -64,336 804,361
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1,600 21,604 8.00 5.08 8,128 109,748
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -200 20,004 -0.99 42.07 -8,414 841,568
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,001 20,204 -4.72 41.40 -41,441 836,446
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,799 21,205 -11.66 40.66 -113,807 862,195
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 24,004 20.00 0.48 1,920 11,522
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 28,000 -12.50
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -1,600 27,896 -5.42
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,000 19,100 -4.98 41.60 -41,600 794,560
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -400 20,100 -1.95 41.70 -16,680 838,170
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,486 24,004 -9.38 41.81 -103,940 1,003,607
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,514 22,490 -6.31 41.23 -62,422 927,263
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 24,004 20.00 0.48 1,920 11,522
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,600 20,004 -7.41 41.78 -66,848 835,767
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1,600 21,604 8.00 5.08 8,128 109,748
2015-01-09 2015-01-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 41,000 41,000
2014-12-19 2014-12-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 32,000 -11.11
2014-12-19 2014-12-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,000 20,500 -4.65 40.19 -40,190 823,895
2014-12-19 2014-12-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -200 20,004 -0.99 40.60 -8,120 812,162
2014-12-19 2014-12-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -3,800 20,204 -15.83 40.13 -152,494 810,787
2014-12-19 2014-12-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 24,004 20.00 0.48 1,920 11,522
2014-12-19 2014-12-17 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise -2,000 35,500 -5.33
2014-12-19 2014-12-17 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 2,000 20,004 11.11 3.88 7,760 77,616
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 29,496 -11.94
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -500 21,500 -2.27 43.73 -21,865 940,195
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -500 22,000 -2.22 43.16 -21,580 949,520
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,065 18,004 -5.58 43.88 -46,732 790,016
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,935 19,069 -13.34 43.32 -127,144 826,069
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 22,004 22.22 5.08 20,320 111,780
2014-12-12 2014-05-19 4/A XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -100 13,922 -0.71 32.23 -3,223 448,706
2014-12-12 2014-05-19 4/A XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,900 14,022 -11.93 31.47 -59,793 441,272
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,082 36,000 -10.18
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -300 22,500 -1.32 34.51 -10,353 776,475
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -700 22,800 -2.98 33.42 -23,394 761,976
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -907 19,940 -4.35 34.54 -31,328 688,728
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -3,175 20,847 -13.22 33.54 -106,490 699,208
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,082 24,022 20.47 0.48 1,959 11,531
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -1,504 33,496 -4.30
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -2,414 0 -100.00
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -400 23,500 -1.67 33.70 -13,480 791,950
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -600 23,900 -2.45 32.64 -19,584 780,096
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,317 19,940 -10.41 33.59 -77,828 669,785
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,601 22,257 -6.71 32.43 -51,920 721,795
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1,504 23,858 6.73 5.08 7,640 121,199
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 2,414 22,354 12.11 1.80 4,345 40,237
2014-10-20 2014-10-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,000 24,500 -3.92 29.12 -29,120 713,440
2014-10-20 2014-10-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -3,918 19,940 -16.42 29.10 -114,014 580,254
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,082 2,414 -62.84
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -200 25,500 -0.78 30.41 -6,082 775,455
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -800 25,700 -3.02 29.27 -23,416 752,239
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,193 23,858 -4.76 30.28 -36,124 722,420
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,889 25,051 -10.34 29.17 -84,272 730,738
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,082 27,940 17.11 1.80 7,348 50,292
2014-09-19 2014-09-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,000 26,500 -3.64 25.50 -25,500 675,750
2014-09-19 2014-09-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -4,000 23,858 -14.36 25.47 -101,880 607,663
2014-09-04 2014-09-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,000 6,496 -38.11
2014-09-04 2014-09-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,000 27,500 -3.51 25.79 -25,790 709,225
2014-09-04 2014-09-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -200 27,858 -0.71 26.40 -5,280 735,451
2014-09-04 2014-09-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -3,800 28,058 -11.93 25.80 -98,040 723,896
2014-09-04 2014-09-03 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,000 31,858 14.36 1.80 7,200 57,344
2014-08-19 2014-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -500 28,500 -1.72 30.00 -15,000 855,000
2014-08-19 2014-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,000 27,858 -6.70 29.53 -59,060 822,647
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -4,316 10,496 -29.14
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -1,684 40,081 -4.03
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,500 29,000 -4.92 29.82 -44,730 864,780
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -100 29,858 -0.33 30.25 -3,025 903,204
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -5,900 29,958 -16.45 29.77 -175,643 891,850
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4,316 35,858 13.68 1.80 7,769 64,544
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1,684 31,542 5.64 0.48 808 15,140
2014-08-13 2014-08-12 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise -8,000 14,812 -35.07
2014-08-13 2014-08-12 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 8,000 29,858 36.60 1.80 14,400 53,744
2014-07-25 2014-07-23 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise -10,000 22,812 -30.48
2014-07-25 2014-07-23 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 10,000 21,858 84.33 1.80 18,000 39,344
2014-07-22 2014-07-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -500 30,500 -1.61 25.50 -12,750 777,750
2014-07-22 2014-07-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -33 11,858 -0.28 26.78 -884 317,557
2014-07-22 2014-07-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,967 11,891 -14.19 26.39 -51,909 313,803
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -6,000 41,765 -12.56
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -499 31,000 -1.58 29.46 -14,701 913,260
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,001 31,499 -3.08 28.77 -28,799 906,226
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -3,094 13,858 -18.25 29.39 -90,933 407,287
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,906 16,952 -14.63 28.55 -82,966 483,980
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 6,000 19,858 43.30 0.48 2,880 9,532
2014-06-20 2014-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -500 32,500 -1.52 34.13 -17,065 1,109,225
2014-06-20 2014-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,000 13,858 -12.61 34.49 -68,980 477,962
2014-06-13 2014-06-11 4 XLRN ACCELERON PHARMA INC
Option to purchase Common Stock
M - Exercise X -6,000 47,765 -11.16
2014-06-13 2014-06-11 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,500 33,000 -4.35 33.25 -49,875 1,097,250
2014-06-13 2014-06-11 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -6,000 15,858 -27.45 33.23 -199,380 526,961
2014-06-13 2014-06-11 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 6,000 21,858 37.84 0.48 2,880 10,492
2014-05-30 2014-05-28 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -6,000 53,765 -10.04
2014-05-30 2014-05-28 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -6,000 15,858 -27.45 30.97 -185,820 491,122
2014-05-30 2014-05-28 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 6,000 21,858 37.84 0.48 2,880 10,492
2014-05-30 2014-05-28 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,500 34,500 -4.17 30.99 -46,485 1,069,155
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -500 36,000 -1.37 31.68 -15,840 1,140,480
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -100 15,858 -0.63 32.23 -3,223 511,103
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,900 15,958 -10.64 31.47 -59,793 502,198
2014-04-24 2014-04-22 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,000 36,500 -2.67 35.75 -35,750 1,304,875
2014-04-24 2014-04-22 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1,936 15,922 -10.84 36.08 -69,851 574,466
2014-04-24 2014-04-22 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2,064 17,858 -10.36 35.64 -73,561 636,459
2013-12-09 2013-12-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 29,000 29,000
2013-09-18 3 XLRN ACCELERON PHARMA INC
Common Stock
19,922
2013-09-18 3 XLRN ACCELERON PHARMA INC
Common Stock
37,500
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)